Nauta Alma J, Engels Ferdi, Knippels Leon M, Garssen Johan, Nijkamp Frans P, Redegeld Frank A
Numico Research, Wageningen, The Netherlands.
Eur J Pharmacol. 2008 May 13;585(2-3):354-60. doi: 10.1016/j.ejphar.2008.02.094. Epub 2008 Mar 18.
Allergies are the result of an inappropriate reaction against innocuous environmental proteins. The prevalence and severity of allergic diseases has increased dramatically during the last decade in developed countries. Allergen-specific T helper (Th) cells play a pivotal role in the pathogenesis of allergic hypersensitivity reactions. These Th cells activate a complex immune reaction that triggers the release of potent mediators and enhances the recruitment of inflammatory cells, which in turn elicit an inflammatory response that leads to the clinical symptoms of allergic disease. The current therapies for allergic diseases focus primarily on control of symptoms and suppression of inflammation, without affecting the underlying cause. However, the knowledge about the pathophysiology of allergic diseases has substantially increased, offering new opportunities for therapeutic intervention. In this review, we will focus on current insights into the mechanism of allergic reactions.
过敏是对无害环境蛋白质产生不适当反应的结果。在过去十年中,发达国家过敏性疾病的患病率和严重程度急剧上升。过敏原特异性辅助性T(Th)细胞在过敏性超敏反应的发病机制中起关键作用。这些Th细胞激活复杂的免疫反应,触发强效介质的释放并增强炎症细胞的募集,进而引发炎症反应,导致过敏性疾病的临床症状。目前针对过敏性疾病的治疗主要集中在症状控制和炎症抑制上,而不影响潜在病因。然而,关于过敏性疾病病理生理学的知识已大幅增加,为治疗干预提供了新机会。在本综述中,我们将重点关注对过敏反应机制的当前见解。